Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiuwei Pan

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
Hepatology (Baltimore, Md.)|February 7, 2019
No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant PatientsNassim Kamar, Qiuwei Pan
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Author response to Letter to the Editor: Hepatitis E prevalence in indigenous communities from Western Brazilian AmazonPengfei Li, Qiuwei Pan
Journal of Hepatology|August 25, 2020
Revisiting the estimation of hepatitis D global prevalenceZhijiang Miao, Qiuwei Pan
The Lancet. Global Health|October 18, 2024
Hepatitis E vaccine and fetal loss: the potential pathophysiological basisKuan Liu, Qiuwei Pan
The Journal of Infectious Diseases|October 3, 2017
Reply to Sayed and MeulemanXinying Zhou, Qiuwei Pan
Gut|June 12, 2024
Porcine-derived pancreatic enzyme replacement therapy linking to chronic hepatitis E: broad implicationsJiahua Zhou, Kuan Liu, Qiuwei Pan
Trends in Pharmacological Sciences|July 6, 2023
Mitochondrial quality control: prime targets for antiviral therapy?Yijin Wang, Peicong Ji, Qiuwei Pan
Trends in Pharmacological Sciences|May 31, 2020
Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-AnalysesZhongren Ma, Jiaye Liu, Qiuwei Pan
Journal of Hepatology|March 27, 2025
Resmetirom directly inhibits lipid accumulation in human liver-derived organoidsJiajing Li, Ibrahim Ayada, Qiuwei Pan
JAMA|December 12, 2023
Sugar-Sweetened Beverages and Risk of Liver DiseaseIbrahim Ayada, Jiajing Li, Qiuwei Pan
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|February 7, 2019
No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant PatientsNassim Kamar, Qiuwei Pan
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Author response to Letter to the Editor: Hepatitis E prevalence in indigenous communities from Western Brazilian AmazonPengfei Li, Qiuwei Pan
Journal of Hepatology|August 25, 2020
Revisiting the estimation of hepatitis D global prevalenceZhijiang Miao, Qiuwei Pan
The Lancet. Global Health|October 18, 2024
Hepatitis E vaccine and fetal loss: the potential pathophysiological basisKuan Liu, Qiuwei Pan
The Journal of Infectious Diseases|October 3, 2017
Reply to Sayed and MeulemanXinying Zhou, Qiuwei Pan
Gut|June 12, 2024
Porcine-derived pancreatic enzyme replacement therapy linking to chronic hepatitis E: broad implicationsJiahua Zhou, Kuan Liu, Qiuwei Pan
Trends in Pharmacological Sciences|July 6, 2023
Mitochondrial quality control: prime targets for antiviral therapy?Yijin Wang, Peicong Ji, Qiuwei Pan
Trends in Pharmacological Sciences|May 31, 2020
Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-AnalysesZhongren Ma, Jiaye Liu, Qiuwei Pan
Journal of Hepatology|March 27, 2025
Resmetirom directly inhibits lipid accumulation in human liver-derived organoidsJiajing Li, Ibrahim Ayada, Qiuwei Pan
JAMA|December 12, 2023
Sugar-Sweetened Beverages and Risk of Liver DiseaseIbrahim Ayada, Jiajing Li, Qiuwei Pan
Pageof 29